← Back to directory

Alberto Lorenzatti

Researcher Next ID · RN-010286

Researcher · Medicine

Instituto Médico DAMIC

, Argentina

Not currently recruitingFunding unknown
Works count
76
Citation count
27,571
H-index
28
i10-index
39

Research interests

Medicine
Immunology and Microbiology
Lipoproteins and Cardiovascular Health
Diabetes, Cardiovascular Risks, and Lipoproteins
Atherosclerosis and Cardiovascular Diseases
Diabetes Treatment and Management
Adipokines, Inflammation, and Metabolic Diseases

Publications

  • Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

    New England Journal of Medicine · 2017 · 10.1056/nejmoa1707914

  • Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial

    The Lancet · 2017 · 10.1016/s0140-6736(17)32247-x

  • Rosuvastatin to Prevent Vascular Events in Men and Women With Elevated C-Reactive Protein

    Obstetrical & Gynecological Survey · 2009 · 10.1097/01.ogx.0000344393.60303.0a

  • Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial

    The Lancet · 2009 · 10.1016/s0140-6736(09)60447-5

  • Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein

    New England Journal of Medicine · 2008 · 10.1056/nejmoa0807646

Current projects

    No projects listed.